[ad_1]
Utrecht-based CryoCloud, a biotech startup, introduced that it has secured €500,000 in a pre-seed spherical of funding led by Nina Capital, with important contributions from Utrecht Well being Seed Fund and ROM Utrecht Area.
The corporate will use the funds to speed up progress and forge partnerships with main corporations and key opinion leaders. The Dutch agency can even use the capital to broaden the capabilities of its platform, better-supporting scientists and streamlining knowledge evaluation.
Robert Englmeier, CEO of CryoCloud, states, “The panorama and throughput of cryo-EM has advanced considerably within the final six years, but the way in which knowledge is analysed remained the identical – resulting in bottlenecks and creating entrance boundaries. Our mission is to make cryo-EM extra accessible and to streamline the analysis course of, which is now potential with our platform.”
CryoCloud: Creating knowledge evaluation platform
Based by Robert Englmeier, Ilja Gubins, and Boy Persoon in 2021, CryoCloud has developed a proprietary knowledge evaluation platform — cryoEM.
The cloud-based knowledge evaluation platform permits the quick and scalable dedication of 3D protein buildings used for drug discovery.
Consequently, it addresses the important challenges confronted by the scientific neighborhood, together with the excessive prices, complexity, and inefficiencies related to conventional cryo-EM compute infrastructure.
By providing scalable cloud storage and knowledge evaluation workflows via a user-friendly net app, the Dutch firm is making superior analysis instruments extra accessible to scientists worldwide.
The corporate’s cloud-based knowledge evaluation platform is accessible by way of a subscription-based net software and is used globally by scientists at universities, biotechs & cryo-EM services.
CryoCloud relies in Utrecht, the Netherlands, the place Robert Englmeier and Ilja Gubins performed their PhD research in utilized and computational cryoEM, respectively.
The investor
Nina Capital is a specialised enterprise capital agency investing solely within the intersection of healthcare and know-how.
Marta-Gaia Zanchi, Founder & Managing Associate at Nina Capital says, “CryoCloud’s modern method to leveraging cloud know-how in cryo-EM isn’t just a significant step for structural biology, however a testomony to the transformative energy of digital options within the life sciences sector.”
Utrecht Well being Seed Fund (UHSF) is an early-stage life sciences & well being funding fund based mostly out of Utrecht, The Netherlands. It’s centered on scalable applied sciences within the fields of Life Sciences (therapeutics and diagnostics), Medical Units, Digital Well being, and Animal Well being within the earliest levels of improvement.
“We’re comfortable to put money into CryoCloud’s options, to make the advanced and expensive strategy of CryoEM evaluation extra accessible to researchers,” says Timo Koopmans, Funding Supervisor on the Utrecht Well being Seed Fund. “Their platform has the potential to drastically broaden the usage of CryoEM within the life sciences.”
[ad_2]
Source link
